Skip to main content
Erschienen in: International Journal of Colorectal Disease 8/2007

01.08.2007 | Review

Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years

verfasst von: Jiun-Ho Ju, Shih-Ching Chang, Huann-Shen Wang, Shung-Haur Yang, Jen-Kae Jiang, Wei-Chone Chen, Tzu-Chen Lin, Hung Hsu, Feng-Ming Wang, Jen-Kou Lin

Erschienen in: International Journal of Colorectal Disease | Ausgabe 8/2007

Einloggen, um Zugang zu erhalten

Abstract

Background and aims

Colorectal cancer (CRC) is the third most common cause of cancer-related death in Taiwan. During the past 20 years, several advances have improved the treatment outcome and quality of life of CRC patients. The purpose of this study was to identify the changes in the clinicopathological features and outcome of CRC over this period.

Materials and methods

Based on the computerized database of the Taipei Veterans General Hospital, between January 1981 and December 2000, 5,474 CRC patients were identified and divided into 2 groups based on the date of treatment (1981–1990 and 1991–2000). The clinicopathological features, outcome, and prognostic factors were analyzed and compared.

Results/findings

The age at onset of cancer was 61 years in the 1980s group and 66 years in the 1990s group. The frequency of rectal tumors decreased from 50% in the 1980s group to 44% in the 1990s group. Tumor, nodes, metastasis (TNM) stage distribution, surgical mortality, and anastomosis leakage were similar in the two groups. However, the 5-year overall survival rate was better in the 1990s group (56%) than that in the 1980s group (50%, P = 0.001). For rectal cancer patients, the local recurrence rate was lower in the 1990s group (6%) than that in the 1980s group (10%, P < 0.01). In stage III CRC, the 5-year overall survival rate was significantly higher in the 1990s group (54%) than that in the 1980s group (48%, P = 0.011). TNM stage was the most important independent prognostic factor for overall and disease-free survivals, followed by differentiation grade, CEA level, and treatment period.

Interpretation/conclusion

Advances in surgical technique and more standard use of chemotherapy have improved CRC outcome.
Literatur
2.
Zurück zum Zitat Health and Vital Statistics (2000) Department of Health, ROC, Taipei Health and Vital Statistics (2000) Department of Health, ROC, Taipei
3.
Zurück zum Zitat Compton CC, Fielding LP, Burgart LJ et al (2000) Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:979–994PubMed Compton CC, Fielding LP, Burgart LJ et al (2000) Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:979–994PubMed
4.
Zurück zum Zitat Gill S, Loprinzi CL, Sargent DJ et al (2004) Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22:1797–1806PubMedCrossRef Gill S, Loprinzi CL, Sargent DJ et al (2004) Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22:1797–1806PubMedCrossRef
5.
Zurück zum Zitat Marsoni S, International Multicenter Pooled Analysis of Colon Cancer Trials Investigators (2001) Efficacy of adjuvant fluorouracil and leucovorin in stage B2 and C colon cancer. International Multicenter Pooled Analysis of Colon Cancer Trials Investigators. Semin Oncol 28:14–19PubMedCrossRef Marsoni S, International Multicenter Pooled Analysis of Colon Cancer Trials Investigators (2001) Efficacy of adjuvant fluorouracil and leucovorin in stage B2 and C colon cancer. International Multicenter Pooled Analysis of Colon Cancer Trials Investigators. Semin Oncol 28:14–19PubMedCrossRef
6.
Zurück zum Zitat Dahlberg M, Pahlman L, Bergstrom R et al (1998) Improved survival in patients with rectal cancer: a population-based register study. Br J Surg 85:515–520PubMedCrossRef Dahlberg M, Pahlman L, Bergstrom R et al (1998) Improved survival in patients with rectal cancer: a population-based register study. Br J Surg 85:515–520PubMedCrossRef
7.
Zurück zum Zitat Enker WE, Thaler HT, Cranor ML et al (1995) Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181:335–346PubMed Enker WE, Thaler HT, Cranor ML et al (1995) Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181:335–346PubMed
8.
Zurück zum Zitat Zhao GP, Zhou ZG, Lei WZ et al (2005) Pathological study of distal mesorectal cancer spread to determine a proper distal resection margin. World J Gastroenterol 11:319–322PubMed Zhao GP, Zhou ZG, Lei WZ et al (2005) Pathological study of distal mesorectal cancer spread to determine a proper distal resection margin. World J Gastroenterol 11:319–322PubMed
9.
Zurück zum Zitat Rullier E, Laurent C, Bretagnol F et al (2005) Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule. Ann Surg 241:465–469PubMedCrossRef Rullier E, Laurent C, Bretagnol F et al (2005) Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule. Ann Surg 241:465–469PubMedCrossRef
10.
Zurück zum Zitat Schiessel R, Novi G, Holzer B et al (2005) Technique and long-term results of intersphincteric resection for low rectal cancer. Dis Colon Rectum 48:1858–1865 (discussion 1865–1867)PubMedCrossRef Schiessel R, Novi G, Holzer B et al (2005) Technique and long-term results of intersphincteric resection for low rectal cancer. Dis Colon Rectum 48:1858–1865 (discussion 1865–1867)PubMedCrossRef
11.
Zurück zum Zitat American Joint Committee on Cancer (1997) AJCC cancer staging manual, 5th edn. Springer, Berlin Heidelberg New York American Joint Committee on Cancer (1997) AJCC cancer staging manual, 5th edn. Springer, Berlin Heidelberg New York
12.
Zurück zum Zitat Mostafa G, Matthews BD, Norton HJ et al (2004) Influence of demographics on colorectal cancer. Am Surg 70:259–264PubMed Mostafa G, Matthews BD, Norton HJ et al (2004) Influence of demographics on colorectal cancer. Am Surg 70:259–264PubMed
13.
Zurück zum Zitat Mensink PB, Kolkman JJ, Van Baarlen J et al (2002) Change in anatomic distribution and incidence of colorectal carcinoma over a period of 15 years: clinical considerations. Dis Colon Rectum 45:1393–1396PubMedCrossRef Mensink PB, Kolkman JJ, Van Baarlen J et al (2002) Change in anatomic distribution and incidence of colorectal carcinoma over a period of 15 years: clinical considerations. Dis Colon Rectum 45:1393–1396PubMedCrossRef
14.
Zurück zum Zitat Takada H, Ohsawa T, Iwamoto S et al (2002) Changing site distribution of colorectal cancer in Japan. Dis Colon Rectum 45:1249–1254PubMedCrossRef Takada H, Ohsawa T, Iwamoto S et al (2002) Changing site distribution of colorectal cancer in Japan. Dis Colon Rectum 45:1249–1254PubMedCrossRef
15.
Zurück zum Zitat Newcomb PA, Norfleet RG, Storer BE et al (1992) Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84:1572–1575PubMedCrossRef Newcomb PA, Norfleet RG, Storer BE et al (1992) Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84:1572–1575PubMedCrossRef
16.
Zurück zum Zitat Selby JV, Friedman GD, Quesenberry CP Jr et al (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326:653–657PubMedCrossRef Selby JV, Friedman GD, Quesenberry CP Jr et al (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326:653–657PubMedCrossRef
17.
18.
Zurück zum Zitat Williams NS, Dixon MF, Johnston D (1983) Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients’ survival. Br J Surg 70:150–154PubMedCrossRef Williams NS, Dixon MF, Johnston D (1983) Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients’ survival. Br J Surg 70:150–154PubMedCrossRef
19.
Zurück zum Zitat Kameda K, Furusawa M, Mori M et al (1990) Proposed distal margin for resection of rectal cancer. Jpn J Cancer Res 81:100–104PubMed Kameda K, Furusawa M, Mori M et al (1990) Proposed distal margin for resection of rectal cancer. Jpn J Cancer Res 81:100–104PubMed
20.
Zurück zum Zitat Simstein NL, Kovalcik PJ, Cross GH (1978) Colorectal carcinoma in patients less than 40 years old. Dis Colon Rectum 21:169–171PubMedCrossRef Simstein NL, Kovalcik PJ, Cross GH (1978) Colorectal carcinoma in patients less than 40 years old. Dis Colon Rectum 21:169–171PubMedCrossRef
21.
Zurück zum Zitat Qing SH, Rao KY, Jiang HY et al (2003) Racial differences in the anatomical distribution of colorectal cancer: a study of differences between American and Chinese patients. World J Gastroenterol 9:721–725PubMed Qing SH, Rao KY, Jiang HY et al (2003) Racial differences in the anatomical distribution of colorectal cancer: a study of differences between American and Chinese patients. World J Gastroenterol 9:721–725PubMed
22.
Zurück zum Zitat Marble K, Banerjee S, Greenwald L (1992) Colorectal carcinoma in young patients. J Surg Oncol 51:179–182PubMedCrossRef Marble K, Banerjee S, Greenwald L (1992) Colorectal carcinoma in young patients. J Surg Oncol 51:179–182PubMedCrossRef
23.
Zurück zum Zitat Faivre-Finn C, Bouvier-Benhamiche AM, Phelip JM et al (2002) Colon cancer in France: evidence for improvement in management and survival. Gut 51:60–64PubMedCrossRef Faivre-Finn C, Bouvier-Benhamiche AM, Phelip JM et al (2002) Colon cancer in France: evidence for improvement in management and survival. Gut 51:60–64PubMedCrossRef
24.
Zurück zum Zitat Finn-Faivre C, Maurel J, Benhamiche AM et al (1999) Evidence of improving survival of patients with rectal cancer in France: a population based study. Gut 44:377–381PubMedCrossRef Finn-Faivre C, Maurel J, Benhamiche AM et al (1999) Evidence of improving survival of patients with rectal cancer in France: a population based study. Gut 44:377–381PubMedCrossRef
25.
Zurück zum Zitat Porter GA, Soskolne CL, Yakimets WW et al (1998) Surgeon-related factors and outcome in rectal cancer. Ann Surg 227:157–167PubMedCrossRef Porter GA, Soskolne CL, Yakimets WW et al (1998) Surgeon-related factors and outcome in rectal cancer. Ann Surg 227:157–167PubMedCrossRef
26.
Zurück zum Zitat Smith JA, King PM, Lane RH et al (2003) Evidence of the effect of ‘specialization’ on the management, surgical outcome and survival from colorectal cancer in Wessex. Br J Surg 90:583–592PubMedCrossRef Smith JA, King PM, Lane RH et al (2003) Evidence of the effect of ‘specialization’ on the management, surgical outcome and survival from colorectal cancer in Wessex. Br J Surg 90:583–592PubMedCrossRef
27.
Zurück zum Zitat Scott KW, Grace RH (1989) Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 76:1165–1167PubMedCrossRef Scott KW, Grace RH (1989) Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 76:1165–1167PubMedCrossRef
28.
Zurück zum Zitat Maurel J, Launoy G, Grosclaude P et al (1998) Lymph node harvest reporting in patients with carcinoma of the large bowel: a French population-based study. Cancer 82:1482–1486PubMedCrossRef Maurel J, Launoy G, Grosclaude P et al (1998) Lymph node harvest reporting in patients with carcinoma of the large bowel: a French population-based study. Cancer 82:1482–1486PubMedCrossRef
29.
Zurück zum Zitat Shen M-Y, Lin J-K, Lin T-C et al (2003) Prognostic significance of lymph node metastasis in resected colorectal cancer. J Soc Colon Rectal Surgeon (Taiwan) 14:7–14 Shen M-Y, Lin J-K, Lin T-C et al (2003) Prognostic significance of lymph node metastasis in resected colorectal cancer. J Soc Colon Rectal Surgeon (Taiwan) 14:7–14
30.
Zurück zum Zitat Buroker TR, O’Connell MJ, Wieand HS et al (1994) Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. J Clin Oncol 12:14–20PubMed Buroker TR, O’Connell MJ, Wieand HS et al (1994) Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. J Clin Oncol 12:14–20PubMed
31.
Zurück zum Zitat Francini G, Petrioli R, Lorenzini L et al (1994) Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology 106:899–906PubMed Francini G, Petrioli R, Lorenzini L et al (1994) Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology 106:899–906PubMed
32.
33.
Zurück zum Zitat Moertel CG, Fleming TR, Macdonald JS et al (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352–358PubMedCrossRef Moertel CG, Fleming TR, Macdonald JS et al (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352–358PubMedCrossRef
34.
Zurück zum Zitat Arkenau HT, Bermann A, Rettig K et al (2003) 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial. Ann Oncol 14:395–399PubMedCrossRef Arkenau HT, Bermann A, Rettig K et al (2003) 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial. Ann Oncol 14:395–399PubMedCrossRef
35.
Zurück zum Zitat Sargent DJ, Goldberg RM, Jacobson SD et al (2001) A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345:1091–1097PubMedCrossRef Sargent DJ, Goldberg RM, Jacobson SD et al (2001) A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345:1091–1097PubMedCrossRef
36.
Zurück zum Zitat Potosky AL, Harlan LC, Kaplan RS et al (2002) Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 20:1192–1202PubMedCrossRef Potosky AL, Harlan LC, Kaplan RS et al (2002) Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 20:1192–1202PubMedCrossRef
37.
Zurück zum Zitat Ayanian JZ, Zaslavsky AM, Fuchs CS et al (2003) Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 21:1293–1300PubMedCrossRef Ayanian JZ, Zaslavsky AM, Fuchs CS et al (2003) Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 21:1293–1300PubMedCrossRef
38.
Zurück zum Zitat Fata F, Mirza A, Craig G et al (2002) Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center. Cancer 94:1931–1938PubMedCrossRef Fata F, Mirza A, Craig G et al (2002) Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center. Cancer 94:1931–1938PubMedCrossRef
39.
Zurück zum Zitat Iwashyna TJ, Lamont EB (2002) Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol 20:3992–3998PubMedCrossRef Iwashyna TJ, Lamont EB (2002) Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol 20:3992–3998PubMedCrossRef
40.
Zurück zum Zitat Jessup JM, Stewart A, Greene FL et al (2005) Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA 294:2703–2711PubMedCrossRef Jessup JM, Stewart A, Greene FL et al (2005) Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA 294:2703–2711PubMedCrossRef
41.
Zurück zum Zitat Fernando NH, Hurwitz HI (2003) Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer. Semin Oncol 30:39–50PubMed Fernando NH, Hurwitz HI (2003) Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer. Semin Oncol 30:39–50PubMed
42.
Zurück zum Zitat O’Dwyer PJ, Benson AB 3rd (2002) Epidermal growth factor receptor-targeted therapy in colorectal cancer. Semin Oncol 29:10–17PubMedCrossRef O’Dwyer PJ, Benson AB 3rd (2002) Epidermal growth factor receptor-targeted therapy in colorectal cancer. Semin Oncol 29:10–17PubMedCrossRef
43.
Zurück zum Zitat Kitisin K, Mishra L (2006) Molecular biology of colorectal cancer: new targets. Semin Oncol 33(Suppl 11):14–23CrossRef Kitisin K, Mishra L (2006) Molecular biology of colorectal cancer: new targets. Semin Oncol 33(Suppl 11):14–23CrossRef
44.
Zurück zum Zitat Wilson RH (2006) Novel therapeutic developments other than EGFR and VEGF inhibition in colorectal cancer. Oncologist 11:1018–1024PubMedCrossRef Wilson RH (2006) Novel therapeutic developments other than EGFR and VEGF inhibition in colorectal cancer. Oncologist 11:1018–1024PubMedCrossRef
Metadaten
Titel
Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years
verfasst von
Jiun-Ho Ju
Shih-Ching Chang
Huann-Shen Wang
Shung-Haur Yang
Jen-Kae Jiang
Wei-Chone Chen
Tzu-Chen Lin
Hung Hsu
Feng-Ming Wang
Jen-Kou Lin
Publikationsdatum
01.08.2007
Verlag
Springer-Verlag
Erschienen in
International Journal of Colorectal Disease / Ausgabe 8/2007
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-007-0293-z

Weitere Artikel der Ausgabe 8/2007

International Journal of Colorectal Disease 8/2007 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.